Stevanato Group S.p.A (STVN) Other Non-Current Liabilities (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Other Non-Current Liabilities came in at $61.9 million in Q1 2026, down 2.28% year-on-year from $63.3 million in Q1 2025, and up 1.94% on a QoQ basis from $60.7 million in Q4 2025.
Stevanato Group S.p.A (STVN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Other Non-Current Liabilities data on file, last reported at $61.9 million in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 2.28% year-over-year to $61.9 million in Q1 2026; TTM through Mar 2026 was $61.9 million, a 2.28% decrease from a year earlier, with the FY2025 full-year figure at $60.7 million, up 190.61% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $61.9 million, up from $60.7 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for STVN reached as high as $64.5 million in Q3 2025 and fell as low as -$67.0 million in Q4 2024.
- Historically, Other Non-Current Liabilities has averaged $28.2 million across 5 years, with a median of $55.3 million in 2024.
- Across the five-year window, Other Non-Current Liabilities plunged 796.8% in 2022 and jumped 1798.68% in 2023, its largest moves.
- Year by year, Other Non-Current Liabilities stood at -$18.5 million in 2022, then sank by 182.58% to -$52.2 million in 2023, then slipped by 28.4% to -$67.0 million in 2024, then soared by 190.61% to $60.7 million in 2025, then increased by 1.94% to $61.9 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $61.9 million in Q1 2026, $60.7 million in Q4 2025, and $64.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.89 Mn |
| Dec 31, 2025 | 60.71 Mn |
| Sep 30, 2025 | 64.48 Mn |
| Jun 30, 2025 | 62.93 Mn |
| Mar 31, 2025 | 63.33 Mn |
| Dec 31, 2024 | -67.00 Mn |
| Sep 30, 2024 | 57.29 Mn |
| Jun 30, 2024 | 55.29 Mn |
| Mar 31, 2024 | 55.28 Mn |
| Dec 31, 2023 | -52.18 Mn |
| Sep 30, 2023 | 56.68 Mn |
| Jun 30, 2023 | 36.97 Mn |
| Mar 31, 2023 | 22.25 Mn |
| Dec 31, 2022 | -18.47 Mn |
| Sep 30, 2022 | 16.13 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 2.04 Mn |
| Dec 31, 2021 | -2.06 Mn |
| Sep 30, 2021 | 2.13 Mn |
| Jun 30, 2021 | 2.21 Mn |